CorVel Corp. $CRVL Shares Bought by Quantinno Capital Management LP

Quantinno Capital Management LP grew its stake in shares of CorVel Corp. (NASDAQ:CRVL) by 328.4% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 81,544 shares of the business services provider’s stock after buying an additional 62,508 shares during the period. Quantinno Capital Management LP owned 0.16% of CorVel worth $4,456,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. Northwestern Mutual Wealth Management Co. acquired a new position in CorVel in the third quarter valued at $31,000. Los Angeles Capital Management LLC acquired a new stake in CorVel during the fourth quarter worth about $33,000. Eagle Bay Advisors LLC acquired a new stake in CorVel during the fourth quarter worth about $37,000. Rockefeller Capital Management L.P. raised its holdings in shares of CorVel by 66.9% in the 4th quarter. Rockefeller Capital Management L.P. now owns 574 shares of the business services provider’s stock worth $39,000 after purchasing an additional 230 shares during the period. Finally, Quarry LP raised its holdings in shares of CorVel by 218.6% in the 3rd quarter. Quarry LP now owns 513 shares of the business services provider’s stock worth $40,000 after purchasing an additional 352 shares during the period. 51.36% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on CRVL. Weiss Ratings upgraded CorVel from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 16th. Wall Street Zen upgraded shares of CorVel from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, CorVel presently has a consensus rating of “Hold”.

Insider Activity

In other news, insider Maxim Shishin sold 2,250 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $60.59, for a total transaction of $136,327.50. Following the completion of the sale, the insider owned 7,050 shares of the company’s stock, valued at approximately $427,159.50. This trade represents a 24.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Jennifer Yoss sold 1,999 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $61.02, for a total transaction of $121,978.98. Following the sale, the vice president directly owned 2,173 shares of the company’s stock, valued at $132,596.46. The trade was a 47.91% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 13,249 shares of company stock worth $807,126. 39.72% of the stock is currently owned by insiders.

CorVel Trading Up 0.2%

CRVL opened at $62.56 on Friday. CorVel Corp. has a twelve month low of $44.83 and a twelve month high of $93.71. The firm has a market cap of $3.19 billion, a price-to-earnings ratio of 27.80 and a beta of 0.98. The company has a fifty day simple moving average of $61.04 and a 200 day simple moving average of $57.87.

CorVel (NASDAQ:CRVL) last posted its quarterly earnings data on Tuesday, August 4th. The business services provider reported $0.63 earnings per share for the quarter. CorVel had a net margin of 11.72% and a return on equity of 29.92%. The company had revenue of $259.93 million during the quarter.

CorVel Profile

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).